Faruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Onyx Pharmaceuticals, Inc. Over the Proposed Sa...
29 August 2013 - 9:00AM
Business Wire
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a
leading national securities firm headquartered in New York City, is
investigating the Board of Directors of Onyx Pharmaceuticals
(“Onyx” or the “Company”) (NasdaqGS:ONXX) for potential breaches of
fiduciary duties in connection with their conduct related to the
sale of the Company to Amgen Inc. (NasdaqGS:AMGN) in a deal valued
at $10.4 billion. Under the terms of the proposed transaction,
Onyx’s stockholders will receive $125 in cash for each share of
Onyx common stock they own, while according to Yahoo! Finance,
there has been at least one financial analyst that set a price
target of $160.00 for Onyx.
Request more information now by clicking here:
www.faruqilaw.com/ONXX. There is no cost or
obligation to you.
The investigation focuses on whether Onyx’s Board of Directors
breached their fiduciary duties to the Company’s stockholders by
failing to conduct an adequate and fair sales process prior to
agreeing to this proposed transaction, whether and by how much this
proposed transaction undervalues the Company to the detriment of
Onyx’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Onyx and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/ONXX or contact Juan E. Monteverde,
Esq. either via e-mail at jmonteverde@faruqilaw.com or by telephone
at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals, Inc. (MM) News Articles